WHO Drug Information Vol. 14, No. 1, 2000
(2000; 81 pages) Ver el documento en el formato PDF
Índice de contenido
Abrir esta carpeta y ver su contenidoGeneral Policy Issues
Abrir esta carpeta y ver su contenidoPersonal Perspectives
Abrir esta carpeta y ver su contenidoReports on Individual Drugs
Abrir esta carpeta y ver su contenidoCurrent Topics
Abrir esta carpeta y ver su contenidoVaccines and Biomedicines
Abrir esta carpeta y ver su contenidoGeneral Information
Abrir esta carpeta y ver su contenidoRegulatory and Safety Matters
Cerrar esta carpetaATC/DDD Classification
Ver el documentoTemporary list
Ver el documentoFinal list
Abrir esta carpeta y ver su contenidoRecent Publications and Documents
Abrir esta carpeta y ver su contenidoInternational Nonproprietary Names for Pharmaceutical Substances (INN)
Ver el documentoSelected WHO Publications of Related Interest
 

Temporary list

The following temporary anatomical therapeutic chemical (ATC) classifications and defined daily doses (DDDs) were agreed at a meeting of the WHO International Working Group for Drug Statistics Methodology which took place on 23 and 24 March 2000. Comments or objections to the decisions from the meeting should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology, e-mail: whocc@nmd.no, before 1 August 2000. If no objections are received before this date, the new ATC codes and DDDs will be considered final and will be included in the January 2001 issue of the ATC index. The inclusion of a substance in the lists does not imply any recommendation of use in medicine or pharmacy.

ATC level

INN/common name

ATC code

New ATC level codes (other than 5th level):

Vasopeptidase inhibitors, plain


C09E

Vasopeptidase Inhibitors, plain


C09EA

Drugs used in alcohol dependence


N07BB

Drugs used in opioid dependence


N07BC

Change of level name:

Previous:
Antismoking agents
New:
Drugs used in addictive disorders


N07B

Previous:
Antismoking agents
New:
Drugs used in nicotine dependence


N07BA

Previous:
Oxytocin and derivatives
New:
Oxytocin and analogues


H01BB

New ATC 5th level codes:


almotriptan

N02CC05


buprenorphine

N07BC01


carbetocin

H01BB03


dihydroemetine

P01AX09


diosmectite

A07BC05


esomeprazole

A02BC05


exemestane

L02BG06


gatifloxacin

J01MA16


gemifloxacin

J01MA15


glucose, combinations

C05BB56


hydroquinone

D11AX11


inositol

A11HA07


isotretinoin, combinations

D10AD54


leflunomide

L04AA13


macrogol

A06AD15


melanoma vaccine

L03AX12


nateglinide

A10BX03


nitisinone

A16AX04


octenidine, combinations

D08AJ57


octenidine, combinations

G01AX16


omapatrilat

C09EA01


propanofen

S01BC09


risedronic acid

M05BA07


sodium fluoride, combinations

A01AA51


technetium (99mTc) sulesomab

V09HA04


thiamphenicol, combinations

J01BA52


verteporfin

L01XX26

ATC code changes:


acamprosate

V03AA03

N07BB03


calcium carbimide

V03AA02

N07BB02


disulfiram

V03AA01

N07BB01


levacetylmethadol

N02AC06

N07BC03


methadone

N02AC02

N07BC02


naltrexone

V03AB30

N07BB04

New DDDs:

INN/common name

DDD

Unit

Route of Administration

ATC code

amodiaquine

0.5

g

O

P01BA06

artemether

0.28

g

O

P01BE02

artemisinin

1

g

O

P01BE01

artenimol**

0.28

g

O

P01BE05

artesunate

0.28

g

O

P01BE03

dihydroemetine

60

mg

P

P01AX09*

exemestane

25

mg

O

L02BG06*

galantamine

24

mg

O

N06DA04

halofantrine

1.5

g

O

P01BX01

ibandronic acid

4

mg

P***

M05BA06

leflunomide

15

mg

O

L04AA13*

macrogol****

10

g

O

A06AD15*

mercaptamine

2

g

O

A16AA04

pioglitazone

30

mg

O

A10BG03

risedronic acid

30

mg

O

M05BA07*

tirofiban

10

mg

P

B01AC17

troglitazone

0.4

g

O

A10BG01

valproic acid

1.5

g

R

N03AG01

zotepine

0.2

g

O

N05AX11

* Temporary ATC code
** Previously: dihydroartemisinin
*** Course dose
*** Refers to macrogol 4000

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013